HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Methyl-2-oxocyclohexancarboxylat
methyl 2-oxocyclohexane-1-carboxylate · AKOS 350 · 2-METHOXYCARBONYLCYCLOHEXANON · 2-METHOXYCARBONYLCYCLOHEXANONE · Methyl 2-cyclohexanonecarboxylate · Methyl 2-oxocyclohexylcarboxylate · METHYL CYCLOHEXANONE-2-CARBOXYLATE · METHYL 2-OXOCYCLOHEXANECARBOXYLATE

Identifikatoren & physikalische Daten
| CAS No. | 41302-34-5 |
|---|---|
| Summenformel | C8H12O3 |
| Durchschnittliche Molmasse | 156,18 g/mol |
| Monoisotopische Masse | 156,07864424 g/mol |
| SMILES | COC(=O)C1CCCCC1=O |
| InChIKey | JEENWEAPRWGXSG-UHFFFAOYSA-N |
| PubChem CID | 170489 |
| EC No. | 255-306-9 |
| DTXSID | DTXSID20884687 |
| Lokaler Name | Methyl-2-oxocyclohexancarboxylat |
Chemische & physikalische Eigenschaften
| XLogP | 1,1 |
|---|---|
| Polarare Oberfläche (TPSA) | 43,4 |
| H-Brücken-Donoren | 0 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 2 |
| Schwere Atome | 11 |
| Formalladung | 0 |
| Komplexität | 174 |
| Siedepunkt | 50 °C/0.2 mmHg (lit.) |
| Dichte | 1.10 g/mL at 20 °C (lit.) |
| Brechungsindex | n20/D 1.483 |
| Flammpunkt | 85 °C |
| Lagerbedingungen | Inert atmosphere,Store in freezer, under -20°C |
| Aggregatzustand | Liquid |
| pKa (Säurekonstante) | 12.04±0.20(Predicted) |
| Farbe | Clear colorless to slightly yellow |
| BRN | 510258 |
| InChI | InChI=1S/C8H12O3/c1-11-8(10)6-4-2-3-5-7(6)9/h6H,2-5H2,1H3 |
| InChIKey | JEENWEAPRWGXSG-UHFFFAOYSA-N |
| SMILES | C1(C(OC)=O)CCCCC1=O |
| LogP (Verteilungskoeffizient) | 0.290 (est) |
| EPA chemische Informationen | Cyclohexanecarboxylic acid, 2-oxo-, methyl ester (41302-34-5) |
Sicherheit & Vorschriften
| Wassergefährdungsklasse (WGK) | 3 |
|---|---|
| TSCA-Inventar-Status | TSCA listed |
| UN-Transportnummer | NA 1993 / PGIII |
| Zollcode | 29183000 |
| Sicherheitshinweise (S) | 23-24/25 |
| Lagerklasse | 10 - Combustible liquids |
Anwendungen & Verwendung
Verwenden
Methyl 2-Oxocyclohexanecarboxylate is a novel intermediate for the preparation of TRPA1 antagonists for treatment of pain and other TRPA1-associated diseases.